Explore Stanford technologies available for licensing:

Stanford scientists have developed the Programmable Antigen-Mediated Cellular Knock-in of T cell (PACK-IT) platform that enables rapid CAR-T cell engineering in hours rather than weeks.

Stanford scientists have discovered that Guanidinylated Serinol Charge-altering Releasable Transporters (GSer-CARTs) can be tuned for selective mRNA delivery to the lung and spleen in a predictable fashion.

Stanford scientists have developed a new DNA-based technology that allows therapeutic genes to be maintained in human cells for extended periods without altering the cell's chromosomes.

Stanford scientists have developed SPACE-seq, a novel technology that integrates spatial epigenomics and transcriptomics into a single platform.

Scientists in Dr. Howard Chang's lab have developed ESCAPE-seq (Enhanced Single Chain Antigen Presentation sequencing) to identify novel neoantigen sequences for the development of immunotherapies.

Researchers at Stanford have developed a system that links inducible gene expression to the presence of extrachromosomal DNA (ecDNA) in cancer cells.

ChiRP (“Chromatin Isolation through RNA Purification”) is a patented RNA “interactomics” technique developed in Prof. Howard Chang's laboratory to capture and identify DNA, RNA or protein molecules that interact with any RNA of interest in a cell.